{"id":196309,"date":"2024-09-17T17:22:56","date_gmt":"2024-09-17T22:22:56","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/09\/immunotherapy-after-surgery-helps-people-with-high-risk-bladder-cancer-live-cancer-free-longer"},"modified":"2024-09-17T17:22:56","modified_gmt":"2024-09-17T22:22:56","slug":"immunotherapy-after-surgery-helps-people-with-high-risk-bladder-cancer-live-cancer-free-longer","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/09\/immunotherapy-after-surgery-helps-people-with-high-risk-bladder-cancer-live-cancer-free-longer","title":{"rendered":"Immunotherapy After Surgery Helps People With High-Risk Bladder Cancer Live Cancer-Free Longer"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/immunotherapy-after-surgery-helps-people-with-high-risk-bladder-cancer-live-cancer-free-longer.jpg\"><\/a><\/p>\n<p>Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder. Researchers found that postsurgical treatment with pembrolizumab (Keytruda), which is approved by the Food and Drug\u2026<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder. Researchers found that postsurgical treatment with pembrolizumab (Keytruda), which is approved by the Food and Drug\u2026<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1506],"tags":[],"class_list":["post-196309","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-food"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/196309","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=196309"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/196309\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=196309"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=196309"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=196309"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}